← Back

Early access

Be first to know when we launch.

Fjord IQ is building the regulatory intelligence layer for the next generation of medtech founders. Join the waitlist and get early access before public launch.

  • Early access to the full Fjord IQ platform
  • Your exact standards, costs, and timelines — before you spend a dollar
  • Priority access to partner lab network for certified testing
  • Regulatory readiness score across six FDA & Health Canada dimensions
  • Founding member pricing locked in at launch

Request early access

✓

You’re on the list.

We’ll be in touch soon.

By signing up you agree to our Privacy Policy.

FAQ

The Questions Asked Before Signing Up

No. Fjord IQ is a decision-support platform, not a replacement for licensed regulatory professionals. We help you understand your exact pathway, costs, and timelines before you engage a consultant — so you go in informed and don't overpay for scoping work.
At launch we cover Class I and Class II medical devices under FDA 510(k) pathways and Health Canada Medical Device Licence applications. Software as a Medical Device (SaMD) is also supported under IEC 62304 and ISO 13485-aligned quality systems.
Yes. Fjord IQ identifies whether your device falls under an exempt classification and maps the remaining obligations — labelling requirements, adverse event reporting, and QSR/QMSR baseline requirements — so you know exactly what "exempt" still means for your device.
Your documents are encrypted in transit and at rest, stored in isolated environments, and never used to train models or shared with third parties. You retain full ownership and can delete your data at any time.
Yes. Health Canada Medical Device Licence pathways are a core part of the platform alongside FDA. You'll get your device class, applicable standards, testing requirements, and submission timelines for both regulators in one place.
Your regulatory readiness score is calculated across six dimensions: device classification accuracy, standards coverage, testing completion, quality management system readiness, labelling compliance, and post-market surveillance planning.